Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (380)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
751 result(s) found, displaying 526 to 550
-
Scheduling decisions (final)Final decisions and reasons for medicines and chemicals referred to the June 2018 scheduling meetings (ACMS #24 and Joint ACMS-ACCS #19) and delegate-only decisions on agricultural and veterinary chemicals.
-
Meeting statementsThe Advisory Committee on Medicines meeting statement for Meeting 11 is now available
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Corporate reportsOverview of what we have done in response to comments in the 2017 TGA stakeholder survey.
-
Corporate reportsARGMD landing page updated with links to new guidance.
-
Corporate reportsThe Australian Government response to the Mesh Senate inquiry has been published.
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 11 statement
-
Scheduling decisions (final)Revised final decisions for matters referred to the March 2018 ACMS/ACCS meetings and delegate-only decisions on agricultural chemicals and NCEs.
-
Corporate reportsDetailed statistical information on our performance
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Corporate reportsInternational engagement: how TGA collaborates to share learnings, align policies, standards and regulatory processes
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 October 2018
-
Meeting statementsThe Advisory Committee on Medicines meeting statement is now available
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 18 meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 19 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in March 2018
-
Corporate reportsPost-market vigilance statistics for 2017
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Corporate reportsDescribes the interaction, role and responsibilities of the TGA and NATA in relation to the regulation of in-house IVDs.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Corporate reportsNew chemical entities registered in 2017 in Australia.
-
Meeting statementsAdvisory Committee on Medicines